Spain· ES:1181294006
RXULTI 3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA,
A brexpiprazol product containing brexpiprazol, registered in Spain by Otsuka Pharmaceutical Netherlands B.V..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- brexpiprazol
- Manufacturer
- Otsuka Pharmaceutical Netherlands B.V.
- Country
- Spain (ES)
- ATC code
- Brexpiprazol
- ATC class
- Brexpiprazol
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo72474128EUR 43.48
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Brexpiprazol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandRxultiAbacus Medicine A/S
- CzechiaRXULTIOtsuka Pharmaceutical Netherlands B.V., Amsterdam
- IrelandRXULTI 3 mg Film-coated tabletOtsuka Pharmaceutical Netherlands B.V.
- IcelandRxultiOtsuka Pharmaceutical Netherlands B.V.*
- NetherlandsRXULTI 3 mg filmomhulde tablettenOtsuka Pharmaceutical Netherlands B.V.
- NorwayRxultiOtsuka Pharmaceutical Netherlands B.V.
- PolandRXULTIOtsuka Pharmaceutical Netherlands B.V.
- BelgiumRxulti 3 mgOtsuka Pharmaceutical Netherlands
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rxulti
- Liechtenstein · Rxulti
- Norway · Rxulti
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5198cd38-1bf5-4bd0-9bc4-3a22f1b7c2e8 GET /v1/drugs/5198cd38-1bf5-4bd0-9bc4-3a22f1b7c2e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1553525883000}",
"nregistro": "1181294006",
"substance": "brexpiprazol"
}See everything about brexpiprazol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.